These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1803 related items for PubMed ID: 8625307

  • 21. Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway.
    Saussede-Aim J, Matera EL, Ferlini C, Dumontet C.
    Cell Motil Cytoskeleton; 2009 Jul; 66(7):378-88. PubMed ID: 19466750
    [Abstract] [Full Text] [Related]

  • 22. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS, Shao ZM, Chen JC, Li XS, Hussain A, Fontana JA.
    J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R.
    Oncogene; 2002 Jan 31; 21(6):964-73. PubMed ID: 11840342
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
    Leung LK, Wang TT.
    Br J Cancer; 1999 Oct 31; 81(3):387-92. PubMed ID: 10507761
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM, Klein RC, Oka M, Cowan KH.
    Clin Cancer Res; 1995 Feb 31; 1(2):235-43. PubMed ID: 9815978
    [Abstract] [Full Text] [Related]

  • 32. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ, Jelovac D, Thiantanawat A, Brodie AM.
    Clin Cancer Res; 2002 Jul 31; 8(7):2378-88. PubMed ID: 12114443
    [Abstract] [Full Text] [Related]

  • 33. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
    Weaver CA, Springer PA, Katzenellenbogen BS.
    Mol Endocrinol; 1988 Oct 31; 2(10):936-45. PubMed ID: 2460749
    [Abstract] [Full Text] [Related]

  • 34. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J, Liu H, Bentrem DJ, Zapf JW, Jordan VC.
    Cancer Res; 2000 Sep 15; 60(18):5097-105. PubMed ID: 11016635
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R.
    Cancer Res; 1997 Aug 15; 57(16):3486-93. PubMed ID: 9270017
    [Abstract] [Full Text] [Related]

  • 38. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
    Huynh H, Yang XF, Pollak M.
    Cell Growth Differ; 1996 Nov 15; 7(11):1501-6. PubMed ID: 8930399
    [Abstract] [Full Text] [Related]

  • 39. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME, Katzenellenbogen BS.
    J Steroid Biochem Mol Biol; 1996 Oct 15; 59(2):121-34. PubMed ID: 9010327
    [Abstract] [Full Text] [Related]

  • 40. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J, Jordan V.
    Endocrinology; 2001 Feb 15; 142(2):838-46. PubMed ID: 11159857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 91.